Fingerprint
Dive into the research topics of 'Phase I dose-escalation study of endoscopic intratumoral injection of OBP-301 (Telomelysin) with radiotherapy in oesophageal cancer patients unfit for standard treatments'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically